It was the year of the original Blackberry, Napster music downloads and AOL Instant Messaging — all ancient technology by today’s standards. Yet 1998 was the most recent year that the FDA approved more than one drug therapy specifically for newborns. Since that time, there has only been one approved, and it is no longer in production. Almost two decades represents an eternity in the fields of science, medicine and technology. So why don’t we have more and newer drugs to improve survival for newborns?
Read more from Mitchell Goldstein, M.D., Medical Director, National Coalition for Infant Health in Future of Personal Health.